Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulation of Anger and Aggression.

Anderson1, Silver

  • 1Psychiatric Ambulatory Services, Columbia University, New York, NY

Seminars in Clinical Neuropsychiatry
|March 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Potential of SERMs for Reducing the Risk of Coronary Heart Disease.

Trends in endocrinology and metabolism: TEM·2001
Same author

On an Antiessential Political Ecology.

Current anthropology·1999
Same author

Identification of a disturbance signal in larval red-legged frogs, Rana aurora.

Animal behaviour·1999
Same author

A reply

European heart journal·1999
Same author

Analysis of the functional coupling between Calmodulin's calcium binding and peptide recognition properties

Biochemistry·1999
Same author

Continuous deformation versus faulting through the continental lithosphere of new zealand

Science (New York, N.Y.)·1999
Same journal

Responses to cancer diagnosis and treatment: posttraumatic stress and posttraumatic growth.

Seminars in clinical neuropsychiatry·2003
Same journal

Mood disturbance in the cancer setting: effects of gender and patient/spouse role.

Seminars in clinical neuropsychiatry·2003
Same journal

The efficacy of behavioral interventions for cancer treatment-related side effects.

Seminars in clinical neuropsychiatry·2003
Same journal

Psychopharmacologic management during cancer treatment.

Seminars in clinical neuropsychiatry·2003
Same journal

Distinguishing fatigue and depression in patients with cancer.

Seminars in clinical neuropsychiatry·2003
Same journal

Delirium in the course of cancer treatment.

Seminars in clinical neuropsychiatry·2003
See all related articles

Traumatic brain injury can cause aggression by affecting brain areas and neurotransmitters. Treatment involves medications for immediate control and long-term prevention of aggressive episodes.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Traumatology

Background:

  • Traumatic brain injury (TBI) frequently leads to behavioral changes, notably anger and aggression.
  • Key brain regions involved in aggression, such as the hypothalamus, limbic system, and prefrontal cortex, are susceptible to TBI.
  • Neurotransmitter systems, including norepinephrine, serotonin, dopamine, and acetylcholine, are disrupted by brain injury, impacting aggression modulation.

Purpose of the Study:

  • To review the neurobiological underpinnings of aggression following TBI.
  • To outline pharmacological strategies for managing aggression post-TBI.
  • To provide recommendations for medication selection in acute and prophylactic treatment of aggression.

Main Methods:

  • Literature review of studies on TBI, aggression, and neurobiology.

Related Experiment Videos

  • Analysis of neurotransmitter roles in aggressive behavior.
  • Categorization of pharmacological treatments into acute and prophylactic strategies.

    • Main Results:

    • TBI-induced damage to specific brain regions and neurotransmitter systems correlates with aggressive behavior.
    • Pharmacological interventions are categorized based on their utility in acute management versus long-term prevention of aggressive episodes.
    • Evidence-based recommendations for specific medication classes are presented for different treatment scenarios.

    Conclusions:

    • Aggression following TBI is a complex phenomenon with identifiable neurobiological correlates.
    • Pharmacological treatment of TBI-related aggression requires a dual approach: immediate control and sustained prophylaxis.
    • Careful selection of medications targeting specific neurochemical pathways is crucial for effective management.